彭换换, 李颖, 袁嘉怿, 陈荆晓, 陈敬华. Heparosan细胞入胞途径及其胞内分布J. 药学学报, 2017,52(3): 474-480. doi: 10.16438/j.0513-4870.2016-1098
引用本文: 彭换换, 李颖, 袁嘉怿, 陈荆晓, 陈敬华. Heparosan细胞入胞途径及其胞内分布J. 药学学报, 2017,52(3): 474-480. doi: 10.16438/j.0513-4870.2016-1098
PENG Huan-huan, LI Ying, YUAN Jia-yi, CHEN Jing-xiao, CHEN Jing-hua. Endocytosis pathway and intracellular distribution of heparosanJ. Acta Pharmaceutica Sinica, 2017,52(3): 474-480. doi: 10.16438/j.0513-4870.2016-1098
Citation: PENG Huan-huan, LI Ying, YUAN Jia-yi, CHEN Jing-xiao, CHEN Jing-hua. Endocytosis pathway and intracellular distribution of heparosanJ. Acta Pharmaceutica Sinica, 2017,52(3): 474-480. doi: 10.16438/j.0513-4870.2016-1098

Heparosan细胞入胞途径及其胞内分布

Endocytosis pathway and intracellular distribution of heparosan

  • 摘要: 本文对肝素前体(heparosan)的细胞摄取途径及其进入细胞后的分布情况进行了研究。通过胞吞途径抑制及细胞探针定位实验发现,MCF-7肿瘤细胞较COS7正常细胞对heparosan的摄取效率更高,具有选择性。Heparosan在MCF-7肿瘤细胞和COS7正常细胞中的内吞过程均为能量依赖。Heparosan主要通过小窝蛋白和巨胞饮介导的内吞进入MCF-7肿瘤细胞,并且主要分布于溶酶体中。

     

    Abstract: In this study, the endocytosis pathway of heparosan and its intracellular distribution were investigated in MCF-7 tumor cells and COS7 normal cells. The endocytosis inhibition and cellular probe location experiments showed that MCF-7 tumor cells took heparosan more efficiently and selectively than COS7 cells. The cellular uptake of heparosan was energy-dependent in both MCF-7 tumor cells and COS7 normal cells. Moreover, the major endocytosis pathway of heparosan into MCF-7 tumor cells was caveolin-mediated endocytosis and macropinocytosis. The internalized heparosan was mainly located in lysosomes of the cells.

     

/

返回文章
返回